Correlation Between Terns Pharmaceuticals and BioXcel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and BioXcel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and BioXcel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and BioXcel Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and BioXcel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of BioXcel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and BioXcel Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and BioXcel Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Terns and BioXcel is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and BioXcel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioXcel Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with BioXcel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioXcel Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and BioXcel Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and BioXcel Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.53 times more return on investment than BioXcel Therapeutics. However, Terns Pharmaceuticals is 1.88 times less risky than BioXcel Therapeutics. It trades about -0.14 of its potential returns per unit of risk. BioXcel Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 651.00 in Terns Pharmaceuticals on August 28, 2024 and sell it today you would lose (72.00) from holding Terns Pharmaceuticals or give up 11.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. BioXcel Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| BioXcel Therapeutics |
Terns Pharmaceuticals and BioXcel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and BioXcel Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and BioXcel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, BioXcel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioXcel Therapeutics will offset losses from the drop in BioXcel Therapeutics' long position.| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
| BioXcel Therapeutics vs. Terns Pharmaceuticals | BioXcel Therapeutics vs. Amylyx Pharmaceuticals | BioXcel Therapeutics vs. Acumen Pharmaceuticals | BioXcel Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |